1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Deals

Cooper Consumer Health Poised To Double In Size With Viatris Acquisition

 
• By Tom Gallen

Cooper Consumer Health says it is set to become a “truly pan-European pure-play leader in consumer healthcare” with the acquisition of Viatris' OTC business in a $2.2bn deal.

M&A written on red and blue blocks
• Source: Shutterstock

Cooper Consumer Health is poised to expand substantially with the acquisition of Viatris’ OTC business.

The Paris, France-based firm has entered into exclusive negotiations to acquire “substantially all” of Viatris’ OTC business for a gross consideration of up to $2.17bn, with completion of the deal subject to consultation with workers’ councils and regulatory approvals. Viatris put the business up for sale last year after describing it as "non core" to the US-based firm's strategy

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

People On The Move: Appointments At Haleon, Wellnex, Orkla

 
• By Tom Gallen

A round-up of the latest consumer health leadership changes: Haleon names Middle East & Africa unit manager; Wellnex Life appoints interim chair; Orkla Health appoints CEO.

US Consumer Health Market People News: Niagen, INW, Hims & Hers, NOW, Tranont, More

 
• By Malcolm Spicer

Amazon executive moves Hims & Hers; INW Manufacturing adds IPA board member as CSO; USC Gerontology School dean joins Niagen advisory board; ‘Be You, NOW’ campaign during Women’s Health Month; direct seller Tranont expands advisory board; Vitamin Shoppe, sports nutrition brands support Team Red, White & Blue cross-US runners; and Powerade supports Morgan's Message.

C&D Divesting Flawless, Spinbrush Lines, Says Gummy Vitamin Brands Might Not Stick

 
• By Malcolm Spicer

C&D reports Q1 net sales dropped 2.4% to $1.48bn, below its guidance for around 1% growth. Its brands’ sales at retail and market share grew in the quarter, but “experienced slowing category growth in the US market” as retailers reduced inventory levels.